PMN
PMN clinical trials: ProMIS Neurosciences Inc.
Every trial on ClinicalTrials.gov where ProMIS Neurosciences Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 2
- Trials linked
- 2
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
PMN on the catalyst calendar · PMN registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 2026Sponsor estimate | NCT06750432PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)ProMis Neurosciences, Inc · Alzheimer Disease, Early Onset | PMNLead | Phase 1 | Active, not recruiting | Locked | Locked | Locked |
| Jul 31, 2024Actual | NCT06105528A Phase 1a Study of PMN310 In Healthy VolunteersProMis Neurosciences, Inc · Healthy Participants | PMNLead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Dec 2026Sponsor estimatePhase 1NCT06750432PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)ProMis Neurosciences, Inc · Alzheimer Disease, Early OnsetActive, not recruitingPMNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2024ActualPhase 1NCT06105528A Phase 1a Study of PMN310 In Healthy VolunteersProMis Neurosciences, Inc · Healthy ParticipantsCompletedPMNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 2 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner